Israeli Researchers develop a bio-sensing technology to predict cancer treatment response
JNS: A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint …
Israeli Researchers develop a bio-sensing technology to predict cancer treatment response Read More